| Literature DB >> 18089406 |
H Sasaki1, T Chikaraishi, S Furuhata, H Tsutsumi, S Miyano, T Nakano, Y Sato, K Kimura, T Takahashi.
Abstract
Basiliximab is potent, relatively safe immunosuppressive induction agent used in transplantation. Prophylactic use at the time of transplantation has been advocated to improve allograft outcomes. We report two cases of kidney transplant recipients with anaphylactic reactions after initial exposure to Basiliximab.Entities:
Mesh：
Substances：
Year: 2007 PMID： 18089406 DOI： 10.1016/j.transproceed.2007.08.104
Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066